ENSIGHT-AI is transforming cardiovascular diagnostics through technology that can identify structural heart disorders from widely available electrocardiograms (ECGs) and wearables. Currently, expensive cardiac imaging is the only way to diagnose many structural heart diseases, so a majority of individuals remain undiagnosed until they develop symptoms. This often means more advanced and less treatable disease at diagnosis. In addition to the dire clinical need for a solution that allows easier and more accessible diagnostics, there is a large commercial need for such technology. Pharmaceutical companies developing therapeutics are challenged by slow trial enrollment and fewer than expected patients on therapies due to the reliance on advanced diagnostic imaging for identifying eligible patients.